TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)
$12.29 -0.04 (-0.3244%)
Analysed TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) News Sources
Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026
23-04-2026
yahoo.com
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium at Johns Hopkins University
29-04-2026
yahoo.com
Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients
06-05-2026
yahoo.com
Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights
11-05-2026
yahoo.com
Tonix Pharmaceuticals to Participate in Two Investor Conferences in May
12-05-2026
yahoo.com
Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026
14-05-2026
yahoo.com
TNXP: Secures Commercial Payer Coverage for Tonmya® to Provide Access for ~35 Million U.S. Patients
20-05-2026
yahoo.com
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting
26-05-2026
yahoo.com
Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology
27-05-2026
yahoo.com
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
28-05-2026
yahoo.com
What is the current price of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?
The current price of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is $12.29.
TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) absolute price change since previous trading day?
The absolute price change of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) since the previous trading day is $-0.04.
TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) percentage price change since previous trading day?
The percentage price change of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) since the previous trading day is -0.3244%.
What is the most recent average sentiment score for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?
The most recent average sentiment score for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?
The most recent sentiment for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is .
SEC-8K** Filing Available For TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.